Ultimately, a shift toward personalized, mechanism-based management may significantly reduce the burden of PTDM and improve graft and patient outcomes
GLP-1 drugs seem to bind to receptors throughout the bodyin our gut, on our immune cells, and throughout the central nervous systemto broadcast the same message: STOP THE ATTACK
Absence of evidence is not evidence of absence
Overactive Bladder in Women: Symptoms, Treatments, and How to Take Back Control If frequent bathroom trips disrupt your life, you are not alone
Disclosures: Yuanji Ma: Nothing to Disclose, li yang: Nothing to Disclose, Lingyao Du: Nothing to Disclose, Lang Bai: Nothing to Disclose, hong Tang: Nothing to Disclose 2101 THERAPEUTIC DOSING OF DOUBLE PLASMA MOLECULAR ADSORPTION SYSTEM IN THE TREATMENT OF SEVERE LIVER DISEASE Yuanji Ma Lingyao Du 1 Lang Bai 1 hong Tang 1 , 1 West China Hospital, Sichuan University Background: The appropriate therapeutic dosing for double plasma molecular adsorption system (DPMAS) in the treatment of severe liver disease remains unclear
Chronic inflammation damages blood vessel walls and creates a pro-coagulant environment
